Cargando…

Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes

We estimated the effectiveness of booster doses of monovalent mRNA COVID-19 vaccines against Omicron-associated severe outcomes among adults in Ontario, Canada. We used a test-negative design to estimate vaccine effectiveness (VE) against hospitalization or death among SARS-CoV-2-tested adults aged...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grewal, Ramandip, Nguyen, Lena, Buchan, Sarah A., Wilson, Sarah E., Nasreen, Sharifa, Austin, Peter C., Brown, Kevin A., Fell, Deshayne B., Gubbay, Jonathan B., Schwartz, Kevin L., Tadrous, Mina, Wilson, Kumanan, Kwong, Jeffrey C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990563/ https://www.ncbi.nlm.nih.gov/pubmed/36882416 http://dx.doi.org/10.1038/s41467-023-36566-1

Ejemplares similares

Author Correction: Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
por: Grewal, Ramandip, et al.
Publicado: (2023)

Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes
por: Buchan, Sarah A., et al.
Publicado: (2022)

Effectiveness of COVID-19 Vaccines Over Time Prior to Omicron Emergence in Ontario, Canada: Test-Negative Design Study
por: Chung, Hannah, et al.
Publicado: (2022)

Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study
por: Jorgensen, Sarah C J, et al.
Publicado: (2023)

Newborn and Early Infant Outcomes Following Maternal COVID-19 Vaccination During Pregnancy
por: Jorgensen, Sarah C. J., et al.
Publicado: (2023)

Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study
por: Chung, Hannah, et al.
Publicado: (2021)

Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study
por: Grewal, Ramandip, et al.
Publicado: (2022)

Background rates of all-cause mortality, hospitalizations, and emergency department visits among nursing home residents in Ontario, Canada to inform COVID-19 vaccine safety assessments
por: Sundaram, Maria, et al.
Publicado: (2021)

Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance
por: Nasreen, Sharifa, et al.
Publicado: (2022)

Estimated Effectiveness of Postpartum Maternal Messenger RNA COVID-19 Vaccination Against Delta and Omicron SARS-CoV-2 Infection and Hospitalization in Infants Younger Than 6 Months
por: Jorgensen, Sarah C. J., et al.
Publicado: (2023)

Risk of preterm birth, small-for-gestational-age at birth, and stillbirth after receiving a booster dose of COVID-19 vaccine during pregnancy
por: Fell, Deshayne, et al.
Publicado: (2023)

Effects of sex and birth weight on non-specific health services use following whole-cell pertussis vaccination: a self-controlled case series analysis
por: Hawken, Steven, et al.
Publicado: (2019)

Pregnancy, fetal, and neonatal outcomes after a first booster dose of covid-19 vaccine during pregnancy in Ontario, Canada: population based, retrospective cohort study
por: Fell, Deshayne B, et al.
Publicado: (2023)

Pregnancy Status at the Time of Coronavirus Disease 2019 Vaccination and Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Magnus, Maria C, et al.
Publicado: (2022)

Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada
por: Buchan, Sarah A., et al.
Publicado: (2022)

Infant Respiratory Outcomes Associated with Prenatal Exposure to Maternal 2009 A/H1N1 Influenza Vaccination
por: Fell, Deshayne B., et al.
Publicado: (2016)

Association Between Cycle Threshold Value and Vaccination Status Among Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Cases in Ontario, Canada, in December 2021
por: Ravindran, Saranyah, et al.
Publicado: (2023)

Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada
por: Buchan, Sarah A., et al.
Publicado: (2023)

Association between newborn screening analyte profiles and infant mortality
por: Fell, Deshayne B., et al.
Publicado: (2019)

Peripartum Outcomes Following COVID-19 Vaccination in Late Pregnancy: Findings from a Population-Based Retrospective Cohort Study in Ontario, Canada
por: El-Chaâr, Darine, et al.
Publicado: (2022)

Temporal trends and determinants of COVID-19 vaccine series initiation after recent pregnancy
por: Török, Eszter, et al.
Publicado: (2023)

Using newborn screening analytes to identify cases of neonatal sepsis
por: Fell, Deshayne B., et al.
Publicado: (2017)

Effectiveness of mRNA booster doses against the omicron variant
por: Zedan, Hadeel T, et al.
Publicado: (2022)

Temporal trends and determinants of COVID-19 vaccine coverage and series initiation during pregnancy in Ontario, Canada, December 2020 to December 2021: A population-based retrospective cohort study
por: Fell, Deshayne B., et al.
Publicado: (2023)

Validation of infant immunization billing codes in administrative data
por: Schwartz, Kevin L, et al.
Publicado: (2015)

Impact of a Publicly Funded Herpes Zoster Immunization Program on the Burden of Disease in Ontario, Canada: A Population-based Study
por: Martins, Diana, et al.
Publicado: (2020)

Impact of national recommendations for routine pertussis vaccination during pregnancy on infant pertussis in Ontario, Canada: a population-based time-series study
por: Antoniou, Tony, et al.
Publicado: (2023)

Omicron variant and booster COVID-19 vaccines
por: Burki, Talha Khan
Publicado: (2022)

The importance of booster vaccination in the context of Omicron wave
por: Wei, Zichun, et al.
Publicado: (2022)

Prioritisation of COVID-19 boosters in the omicron era
por: Irving, Stephanie A, et al.
Publicado: (2022)

COVID vaccine booster doses for omicron variants
por: Burki, Talha
Publicado: (2022)

Durability of Bivalent Boosters against Omicron Subvariants
por: Lin, Dan-Yu, et al.
Publicado: (2023)

COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents
por: Canaday, David H., et al.
Publicado: (2022)

Risk of preterm birth, small for gestational age at birth, and stillbirth after covid-19 vaccination during pregnancy: population based retrospective cohort study
por: Fell, Deshayne B, et al.
Publicado: (2022)

Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization
por: Doria-Rose, Nicole A., et al.
Publicado: (2021)

Prevalence of Co-Infections with Respiratory Viruses in Individuals Investigated for SARS-CoV-2 in Ontario, Canada
por: Peci, Adriana, et al.
Publicado: (2021)

Omicron variant: a booster depending on infection histories
por: Wang, Jiayu, et al.
Publicado: (2023)

Effectiveness of Bivalent Boosters against Severe Omicron Infection
por: Lin, Dan-Yu, et al.
Publicado: (2023)

Association between newborn screening analytes and hypoxic ischemic encephalopathy
por: Wilson, Lindsay A., et al.
Publicado: (2019)

Temporal trends in the frequency of twins and higher-order multiple births in Canada and the United States
por: Fell, Deshayne B, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5gnd65ppnjrlo9lfuf131cr1sb